Home LiteratureArticle Details
PMID: 1384327 Published · ppublish English Editorial Research Support, Non-U.S. Gov't Comment

Cystic fibrosis genotypes and views on screening are both heterogeneous and population related.

American journal of human genetics ·Vol. 51 ·No. 5 ·1992-11-00 ·Pages 943-50

Scriver CR, Fujiwara TM

Abstract

暂无摘要

Related Genes
CFTR
MeSH Terms
Attitude to Health Cystic Fibrosis/genetics Cystic Fibrosis Transmembrane Conductance Regulator Genetic Carrier Screening Genetic Testing Genotype Humans Membrane Proteins/genetics
Chemicals
CFTR protein, human Membrane Proteins Cystic Fibrosis Transmembrane Conductance Regulator
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Scriver C R
Fujiwara T M
References (75)
75 references, click to expand
  1. Abnormal ion permeation through cystic fibrosis respiratory epithelium.
    Science. 1983 Sep 9;221(4615):1067-70 PMID: 6308769
  2. Beta-thalassemia disease prevention: genetic medicine applied.
    Am J Hum Genet. 1984 Sep;36(5):1024-38 PMID: 6496471
  3. No CFTR: are CF symptoms milder?
    Nat Genet. 1992 Apr;1(1):10 PMID: 1284545
  4. Lung involvement, the delta F508 mutation and DNA haplotype analysis in cystic fibrosis.
    Hum Genet. 1992 Mar;88(6):639-41 PMID: 1348048
  5. Association of a nonsense mutation (W1282X), the most common mutation in the Ashkenazi Jewish cystic fibrosis patients in Israel, with presentation of severe disease.
    Am J Hum Genet. 1992 Jan;50(1):222-8 PMID: 1370365
  6. Public and private views of identity: acceptance of the 1990 Ross Award.
    Clin Invest Med. 1991 Apr;14(2):167-75 PMID: 2060191
  7. Cystic fibrosis carrier screening by DNA analysis: a pilot study of attitudes among participants.
    Am J Hum Genet. 1991 Jul;49(1):240-2 PMID: 2063873
  8. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels.
    Pediatrics. 1990 Jun;85(6):1001-7 PMID: 2187173
  9. Carrier screening for cystic fibrosis.
    Am J Hum Genet. 1990 Oct;47(4):603-5 PMID: 2220802
  10. The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).
    N Engl J Med. 1990 Nov 29;323(22):1517-22 PMID: 2233932
  11. Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis.
    N Engl J Med. 1990 Feb 1;322(5):291-6 PMID: 2296270
  12. Screening for cystic fibrosis; public policy and personal choices.
    N Engl J Med. 1990 Feb 1;322(5):328-9 PMID: 2296274
  13. A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers.
    Chest. 1990 Jun;97(6):1310-6 PMID: 2347214
  14. Community attitudes to cystic fibrosis carrier screening.
    Prenat Diagn. 1990 Apr;10(4):275-6 PMID: 2367344
  15. Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutations of the cystic fibrosis gene.
    Am J Hum Genet. 1989 Mar;44(3):307-18 PMID: 2563631
  16. Why is the cystic fibrosis gene so frequent?
    Hum Genet. 1989 Dec;84(1):1-5 PMID: 2691388
  17. Identification of the cystic fibrosis gene: chromosome walking and jumping.
    Science. 1989 Sep 8;245(4922):1059-65 PMID: 2772657
  18. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR).
    Cell. 1992 Feb 21;68(4):809-18 PMID: 1371239
  19. Cystic fibrosis: molecular biology and therapeutic implications.
    Science. 1992 May 8;256(5058):774-9 PMID: 1375392
  20. Analysis of four diverse population groups indicates that a subset of cystic fibrosis mutations occur in common among Caucasians.
    Am J Hum Genet. 1992 Jun;50(6):1185-94 PMID: 1376017
  21. Screening for five mutations detects 97% of cystic fibrosis (CF) chromosomes and predicts a carrier frequency of 1:29 in the Jewish Ashkenazi population.
    Am J Hum Genet. 1992 Nov;51(5):951-6 PMID: 1384328
  22. Cystic fibrosis mutations in French Canadians: three CFTR mutations are relatively frequent in a Quebec population with an elevated incidence of cystic fibrosis.
    Am J Med Genet. 1992 Feb 1;42(3):360-4 PMID: 1536179
  23. Discrimination as a consequence of genetic testing.
    Am J Hum Genet. 1992 Mar;50(3):476-82 PMID: 1539589
  24. Carrier screening for cystic fibrosis: a pilot study of the attitudes of pregnant women.
    Am J Public Health. 1992 May;82(5):723-5 PMID: 1566951
  25. Principles and practicalities of carrier screening: attitudes of recent parents.
    J Med Genet. 1992 May;29(5):313-9 PMID: 1583658
  26. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
    Lancet. 1991 Feb 16;337(8738):392-4 PMID: 1671425
  27. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity.
    Science. 1991 Jul 12;253(5016):202-5 PMID: 1712984
  28. In vivo cell-specific expression of the cystic fibrosis transmembrane conductance regulator.
    Nature. 1991 Oct 3;353(6343):434-7 PMID: 1716739
  29. Detection of over 98% cystic fibrosis mutations in a Celtic population.
    Nat Genet. 1992 Jun;1(3):188-91 PMID: 1284639
  30. Tracing the mutations in cystic fibrosis by means of closely linked DNA markers.
    Am J Hum Genet. 1989 Mar;44(3):303-6 PMID: 2916577
  31. Hypothesis: a selective advantage for cystic fibrosis heterozygotes.
    Am J Phys Anthropol. 1987 Sep;74(1):39-45 PMID: 3318490
  32. A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers.
    Am J Hum Genet. 1988 Jun;42(6):808-15 PMID: 3369446
  33. Incidence in Italy, genetic heterogeneity, and segregation analysis of cystic fibrosis.
    Am J Hum Genet. 1985 Mar;37(2):338-49 PMID: 3985009
  34. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay-Sachs gene detected by high school screening in Montreal.
    Am J Med Genet. 1984 Aug;18(4):769-78 PMID: 6486173
  35. Chloride impermeability in cystic fibrosis.
    Nature. 1983 Feb 3;301(5899):421-2 PMID: 6823316
  36. The cystic fibrosis gene: medical and social implications for heterozygote detection.
    JAMA. 1990 May 23-30;263(10):2777-83 PMID: 11653890
  37. Restriction site generating-polymerase chain reaction (RG-PCR) for the probeless detection of hidden genetic variation: application to the study of some common cystic fibrosis mutations.
    Mol Cell Probes. 1992 Feb;6(1):1-7 PMID: 1347644
  38. Prenatal screening for cystic fibrosis.
    Lancet. 1992 Jul 25;340(8813):214-6 PMID: 1353143
  39. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium.
    Cell. 1992 Jan 10;68(1):143-55 PMID: 1370653
  40. Regulation of plasma membrane recycling by CFTR.
    Science. 1992 Apr 24;256(5056):530-2 PMID: 1373908
  41. Cystic fibrosis transmembrane conductance regulator: a chloride channel with novel regulation.
    Neuron. 1992 May;8(5):821-9 PMID: 1375035
  42. Genetic determination of exocrine pancreatic function in cystic fibrosis.
    Am J Hum Genet. 1992 Jun;50(6):1178-84 PMID: 1376016
  43. Cystic fibrosis patients bearing both the common missense mutation Gly----Asp at codon 551 and the delta F508 mutation are clinically indistinguishable from delta F508 homozygotes, except for decreased risk of meconium ileus.
    Am J Hum Genet. 1992 Aug;51(2):245-50 PMID: 1379413
  44. Development, multiplexing, and application of ARMS tests for common mutations in the CFTR gene.
    Am J Hum Genet. 1992 Aug;51(2):251-62 PMID: 1379414
  45. Eugenics and genetic discrimination.
    Am J Hum Genet. 1992 Mar;50(3):457-9 PMID: 1531726
  46. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    N Engl J Med. 1992 Mar 19;326(12):812-5 PMID: 1538726
  47. Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis.
    JAMA. 1992 Apr 1;267(13):1794-7 PMID: 1545465
  48. Effects of genetic screening on perceptions of health: a pilot study.
    J Med Genet. 1992 Jan;29(1):24-6 PMID: 1552538
  49. Cystic fibrosis: community knowledge and attitudes towards carrier screening and prenatal diagnosis.
    Clin Genet. 1992 Apr;41(4):189-96 PMID: 1576756
  50. Detection of multiple cystic fibrosis mutations by reverse dot blot hybridization: a technology for carrier screening.
    Hum Genet. 1992 May;89(2):163-8 PMID: 1587526
  51. Attitudes towards prenatal diagnosis and carrier screening for cystic fibrosis among the parents of patients in a paediatric cystic fibrosis clinic.
    J Med Genet. 1992 Jul;29(7):490-1 PMID: 1640429
  52. Defective acidification of intracellular organelles in cystic fibrosis.
    Nature. 1991 Jul 4;352(6330):70-3 PMID: 1712081
  53. The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.
    J Med Genet. 1991 May;28(5):317-21 PMID: 1713973
  54. General population screening for cystic fibrosis is premature.
    Am J Hum Genet. 1992 Feb;50(2):438-9 PMID: 1734723
  55. Attitudes toward genetic testing of Amish, Mennonite, and Hutterite families with cystic fibrosis.
    Am J Public Health. 1992 Feb;82(2):236-42 PMID: 1739154
  56. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis.
    N Engl J Med. 1991 Aug 22;325(8):533-8 PMID: 1857389
  57. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    N Engl J Med. 1991 Sep 12;325(11):769-74 PMID: 1870650
  58. What drives neonatal screening programs?
    N Engl J Med. 1991 Sep 12;325(11):802-4 PMID: 1870654
  59. Cystic fibrosis screening and community genetics.
    J Med Genet. 1991 Aug;28(8):575 PMID: 1920375
  60. Benign missense variations in the cystic fibrosis gene.
    Am J Hum Genet. 1990 Oct;47(4):611-5 PMID: 1977306
  61. Attitudes toward abortion among parents of children with cystic fibrosis.
    Am J Public Health. 1991 Aug;81(8):992-6 PMID: 1854017
  62. What do young people think about screening for cystic fibrosis?
    J Med Genet. 1991 May;28(5):322-4 PMID: 1865469
  63. Screening for carriers of cystic fibrosis through primary health care services.
    BMJ. 1991 Aug 31;303(6801):504-7 PMID: 1912861
  64. Abnormal distribution of cystic fibrosis delta F508 allele in adults with chronic bronchial hypersecretion.
    Lancet. 1990 Jun 2;335(8701):1340 PMID: 1971393
  65. Cystic fibrosis and congenital absence of the vas deferens.
    N Engl J Med. 1991 Jul 4;325(1):64-5 PMID: 2046716
  66. A pilot study of aerosolized amiloride for the treatment of lung disease in cystic fibrosis.
    N Engl J Med. 1990 Apr 26;322(17):1189-94 PMID: 2157983
  67. Cystic fibrosis screening and community genetics.
    J Med Genet. 1990 Aug;27(8):475-9 PMID: 2213841
  68. Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease.
    N Engl J Med. 1990 Dec 13;323(24):1685-9 PMID: 2233965
  69. Pancreatic function in infants identified as having cystic fibrosis in a neonatal screening program.
    N Engl J Med. 1990 Feb 1;322(5):303-8 PMID: 2296272
  70. The American Society of Human Genetics statement on cystic fibrosis screening.
    Am J Hum Genet. 1990 Feb;46(2):393 PMID: 2301404
  71. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.
    Science. 1989 Sep 8;245(4922):1066-73 PMID: 2475911
  72. Identification of the cystic fibrosis gene: genetic analysis.
    Science. 1989 Sep 8;245(4922):1073-80 PMID: 2570460
  73. Carrier screening in CF.
    Nature. 1989 Nov 9;342(6246):131 PMID: 2812012
  74. Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study.
    Am J Hum Genet. 1986 Dec;39(6):681-93 PMID: 3026171
  75. No evidence for genetic heterogeneity in cystic fibrosis.
    Am J Hum Genet. 1988 Jan;42(1):184 PMID: 3337109
Article Info
Journal
American journal of human genetics
Abbr.
Am J Hum Genet
ISSN
0002-9297
Published
1992-11-00
Pages
943-50
Language
English
Region
United States
NLM ID
0370475
PMCID
PMC1682854
Subset
IM
Corrections
CommentOn
PMID: 1384328
External Links
PubMed source PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2